Philip Rowlings
Is this you? Claim this profileThis page collects the articles indexed under the name Philip Rowlings. Profiles are grouped by name, so it can include work by someone else who shares it until the author claims the profile and confirms which papers are theirs.
Publications 10
- Outpatient rituximab, ifosfamide, etoposide (R-IE) in patients older than 60 years with relapsed or refractory diffuse large B-cell lymphoma who are not candidates for stem cell transplantation.
- Clinical use of SNP-microarrays for the detection of genome-wide changes in haematological malignancies.
- Quality of life is maintained with ixazomib maintenance in post-transplant newly diagnosed multiple myeloma: the TOURMALINE-MM3 trial.
- 'Real-world' Australian experience of pomalidomide for relapsed and refractory myeloma.
- Idarubicin Dose Escalation During Consolidation Therapy for Adult Acute Myeloid Leukemia.
- Evaluation of cardiovascular ischemic event rates in dasatinib-treated patients using standardized incidence ratios.
- Detection of complex genomic signatures associated with risk in plasma cell disorders.
- To adhere or not to adhere: Rates and reasons of medication adherence in hematological cancer patients.
- Comparing Outcomes with Bone Marrow or Peripheral Blood Stem Cells as Graft Source for Matched Sibling Transplants in Severe Aplastic Anemia across Different Economic Regions.
- A systematic evaluation of the safety and toxicity of fingolimod for its potential use in the treatment of acute myeloid leukaemia.
Is this you?
Claim this profile to connect it to your account. You will be able to remove papers that are not yours, fold in other spellings of your name, and show your affiliation and photo here.
Institutions on these papers
- Calvary Mater Newcastle Hospital · AU 4
- University of Newcastle Australia · AU 2
- The University of Sydney · AU 1
- Hunter Cancer Research Alliance · AU 1
From OpenAlex, for papers with a DOI.